Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

When used in a treat-to-target approach, therapies for mucosal healing may favorably modify the natural history of inflammatory bowel disease (IBD), reducing the need for steroids and risk of hospitalization.

Dose Escalation Patterns of Advanced Therapies in Crohn's Disease and Ulcerative Colitis: A Systematic Literature Review

Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD - Mayo Clinic

Inflammatory bowel disease biobank research update - Mayo Clinic

PDF) Radiographic evaluation of ulcerative colitis

What Not to Miss at Advances in Inflammatory Bowel Disease 2018

A comprehensive, evidence-based resource that includes up-to-date information on Crohn’s disease and ulcerative colitis. Fast shipping. Get your copy

Mayo Clinic on Crohn’s Disease & Ulcerative Colitis - Mayo Clinic Press

Optimizing Advanced Therapies in Ulcerative Colitis by Integritas Communications - Issuu

FDA Approves Ozanimod for Ulcerative Colitis

Life, Free Full-Text

The long-term effect of biologics in patients with ulcerative colitis emerging from a large Japanese cohort

Meet The Faculty - Advanced Inflammatory Bowel Disease Fellowship (Florida) - Mayo Clinic College of Medicine & Science